"We are delighted to welcome Dr. Khachatryan to Dymicron's Board," said Dymicron Chairman and CEO Alan Layton. "Dr. Khachatryan's highly accomplished track record and vast experience with cervical arthroplasty will be tremendously helpful to our company as we prepare for FDA clinical trials in the US and commercialization in select countries outside the US with our CE Mark."
Dr. Katchatryan is a board-certified orthopedic surgeon, with extensive experience in minimally invasive procedures, motion preservation technology, artificial disc replacement and non-fusion technologies. He has been a clinical investigator in a range of FDA clinical trials and has helped to train hundreds of surgeons advanced spinal surgery techniques.
"I am excited and honored to join the Dymicron team at this important juncture in the company's development,” said Dr. Khachatryan. “I believe the natural constrained motion characteristics of the distinctive Tri-Lobe design, combined with the unrivaled wear properties of the Polycrystalline Diamond material, has the real potential to position the Triadyme-C as an emerging leader in next-generation cervical arthroplasty devices."